Table 5. Significant prognostic factors on univariate analysis for OS.

		Median	0.95LCL–0.95UCL	p	HR	0.95LCL–0.95UCL
TKI used in 1L of therapy	No	8.11	6.31–NA	0.0001
	Yes	48.59	37.85–NA		0.2168	0.0941–0.4997
TKI used in any line of therapy	NO	8.11	6.31–NA	0.0001
	Yes	NA	37.85–NA		0.1673	0.07131–0.3923
ECOG PS at presentation	0–2	48.6	25.3–NA	0.0001
	3–4	2	0.49–NA		9.935	4.192–23.55